Imbed Biosciences Announces Study Results
Imbed Biosciences announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte Matrix, in complex chronic wounds.
Imbed Biosciences announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte Matrix, in complex chronic wounds.
SHINE announces first sales of its non-carrier-added lutetium-177
Sankaralingam said the chip has the potential to speed up development of artificial intelligence and machine learning, which has been hindered by hardware that can’t keep up.
Recent Comments